Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:438-448
doi: 10.1161/CIRCULATIONAHA.104.481259
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mancini, D.
Right arrow Articles by Burkhoff, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mancini, D.
Right arrow Articles by Burkhoff, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Other heart failure

(Circulation. 2005;112:438-448.)
© 2005 American Heart Association, Inc.


New Drugs and Technologies

Mechanical Device–Based Methods of Managing and Treating Heart Failure

Donna Mancini, MD; Daniel Burkhoff, MD, PhD

From the Division of Cardiology, Columbia University Medical School, New York (D.M., D.B.), and IMPULSE Dynamics, Orangeburg (D.B.), NY.

Correspondence to Daniel Burkhoff, MD, PhD, Columbia University, Division of Cardiology, Black Building 812, 650 W 168th St, New York, NY 10032.

Despite advances in pharmacological treatments aimed at neurohormonal blockade for heart failure in the setting of left ventricular pump dysfunction, there is still a growing number of patients with advanced symptoms who suffer significant morbidity and mortality. Mechanical stresses and chronic neurohormonal activation conspire to propagate maladaptive ventricular remodeling responsible for the insidious nature of this disease. Recent studies suggest that further pharmacological neurohormonal blockade may not be safe or effective, which has driven development of devices for this patient population. Furthermore, such devices may target fundamental pathophysiological abnormalities that are largely hemodynamic and mechanical in nature that are not addressed by available pharmacological agents. The profound reverse remodeling routinely associated with left ventricular assist device use, reviewed in detail, further validates device-based approaches and should inspire research to find ways to make this recovery more complete and permanent. Accordingly, this review focuses on the multitude of mechanical device–based approaches currently being investigated to manage and treat this population. From devices for monitoring patient status to anticipate congestive heart failure exacerbations and preemptively adjust therapy to devices to support preterminal patients with end-stage disease, it is recognized that these device-based approaches will assume an increasingly important role in treating the growing number of patients with advanced heart failure.


Key Words: heart failure • transplantation • disease management




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
C. Butter, S. Rastogi, H.-H. Minden, J. Meyhofer, D. Burkhoff, and H. N. Sabbah
Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure.
J. Am. Coll. Cardiol., May 6, 2008; 51(18): 1784 - 1789.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. S. Groth, B. A. Whitson, J. D'Cunha, R. S. Andrade, and M. A. Maddaus
Diaphragmatic hernias after sequential left ventricular assist device explantation and orthotopic heart transplant: Early results of laparoscopic repair with polytetrafluoroethylene
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 38 - 43.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka
Long-Term Mechanical Circulatory Support
Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628.
[Full Text]


Home page
NEJMHome page
K. L. Baughman and J. A. Jarcho
Bridge to Life -- Cardiac Mechanical Support
N. Engl. J. Med., August 30, 2007; 357(9): 846 - 849.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Morley, K. Litwak, P. Ferber, P. Spence, R. Dowling, B. Meyns, B. Griffith, and D. Burkhoff
Hemodynamic effects of partial ventricular support in chronic heart failure: Results of simulation validated with in vivo data
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Burkhoff and A. S. Wechsler
Surgical ventricular remodeling: A balancing act on systolic and diastolic properties.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 459 - 463.
[Full Text] [PDF]